← Back to headlines
Precigen Stock Jumps After Q1 Beat and Papzimeos Launch
Precigen's stock saw a significant jump following its first-quarter earnings beat, driven by the momentum from the launch of its Papzimeos product.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
